Croma-Pharma GmbH Celebrates FDA Approval of Obagi saypha® MagIQ™ in the U.S. Market Croma-Pharma GmbH proudly announces the FDA approval of Obagi saypha® MagIQ™, marking a significant milestone for aesthetic medicine in the U.S.

Croma-Pharma GmbH Celebrates FDA Approval of Obagi saypha® MagIQ™ in the U.S. Market #United_States #New_York #Croma-Pharma #Obagi #saypha_MagIQ